Barclays PLC Cytokinetics Inc Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Barclays PLC holds 762,247 shares of CYTK stock, worth $37 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

762,247

Previous 464,723 64.02%

Holding current value

$37 Million

Previous $38.8 Million 37.73%

% of portfolio

0.02%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $19 Million - $32.2 Million	297,524 Added 64.02%	762,247 $53.4 Million
Q4 2023 Feb 15, 2024	SELL	$26.88 - $83.49 $2.89 Million - $8.98 Million	-107,544 Reduced 18.79%	464,723 $38.8 Million
Q3 2023 Nov 07, 2023	BUY	$29.46 - $36.61 $12.6 Million - $15.6 Million	426,921 Added 293.73%	572,267 $16.9 Million
Q2 2023 Aug 03, 2023	SELL	$32.62 - $40.75 $6.39 Million - $7.98 Million	-195,926 Reduced 57.41%	145,346 $4.74 Million
Q1 2023 May 04, 2023	SELL	$33.36 - $45.71 $1.87 Million - $2.56 Million	-55,915 Reduced 14.08%	341,272 $12 Million

Q4 2022 Feb 13, 2023	SELL	$35.77 - $51.11 $145,440 - $207,813	-4,066 Reduced 1.01%	397,187 $18.2 Million
Q3 2022 Nov 03, 2022	BUY	$38.54 - $54.52 $2.81 Million - $3.98 Million	72,972 Added 22.23%	401,253 $19.4 Million
Q2 2022 Aug 12, 2022	BUY	$33.93 - $48.92 $8.38 Million - $12.1 Million	247,104 Added 304.4%	328,281 $12.9 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $726,012 - $1.12 Million	-24,412 Reduced 23.12%	81,177 $2.99 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $765,833 - $1.03 Million	22,295 Added 26.77%	105,589 $4.81 Million
Q3 2021 Nov 09, 2021	BUY	$18.54 - $35.74 $559,036 - $1.08 Million	30,153 Added 56.74%	83,294 $2.98 Million
Q2 2021 Aug 13, 2021	SELL	$19.79 - $26.99 $1.64 Million - $2.23 Million	-82,746 Reduced 60.89%	53,141 $1.05 Million
Q1 2021 May 13, 2021	SELL	$18.57 - $25.68 $918,193 - $1.27 Million	-49,445 Reduced 26.68%	135,887 $3.16 Million
Q4 2020 Feb 11, 2021	SELL	$15.26 - $28.61 $144,405 - $270,736	-9,463 Reduced 4.86%	185,332 $3.85 Million
Q3 2020 Nov 12, 2020	BUY	$20.58 - $28.96 $1.27 Million - $1.78 Million	61,488 Added 46.13%	194,795 $4.22 Million
Q2 2020 Aug 12, 2020	BUY	$11.15 - $24.64 $941,026 - $2.08 Million	84,397 Added 172.56%	133,307 $3.14 Million
Q1 2020 May 13, 2020	SELL	$8.75 - $16.3 $334,083 - $622,350	-38,181 Reduced 43.84%	48,910 $577,000
Q4 2019 Feb 10, 2020	SELL	$7.95 - $11.84 $195,975 - $291,867	-24,651 Reduced 22.06%	87,091 $924,000
Q3 2019 Nov 14, 2019	BUY	$10.82 - $14.25 $506,192 - $666,657	46,783 Added 72.02%	111,742 $1.27 Million
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $247,467 - $350,190	31,128 Added 92.01%	64,959 $731,000
Q1 2019 May 15, 2019	BUY	$5.95 - $10.19 $64,152 - $109,868	10,782 Added 46.78%	33,831 $274,000
Q4 2018 Feb 14, 2019	SELL	$5.91 - $9.29 $194,746 - $306,124	-32,952 Reduced 58.84%	23,049 $145,000
Q3 2018 Nov 14, 2018	BUY	$6.4 - $9.85 $202,681 - $311,939	31,669 Added 130.15%	56,001 $552,000
Q2 2018 Aug 14, 2018	BUY	$6.9 - $9.9 $4,974 - $7,137	721 Added 3.05%	24,332 $202,000
Q1 2018 May 15, 2018	BUY	$7.2 - $10.05 $31,060 - $43,355	4,314 Added 22.36%	23,611 $171,000
Q4 2017 Feb 14, 2018	BUY	$7.25 - $15.65 $27,506 - $59,376	3,794 Added 24.47%	19,297 $157,000
Q3 2017 Nov 14, 2017	BUY	$12.0 - $15.0 $186,036 - $232,545	15,503	15,503 $225,000

Others Institutions Holding CYTK

# of Institutions

459

Shares Held

108M

Call Options Held

7.2M

Put Options Held

6.2M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.57B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account